Association of chronic opioid therapy and opioid use disorder with COVID-19-related hospitalization and mortality: Evidence from three health systems in the United States.  Nguyen AP, Binswanger IA, Narwaney KJ, Ford MA, McClure DL, Rinehart...

Impact of the COVID-19 pandemic on psychotropic prescribing: a systematic review.  Mahesarajah S, El Asmar ML, Irwin R, Vallejo-Vaz AJ, Mastellos N, Dharmayat KI.  BMJ Open. 2024 Sep 25;14(9):e076791. doi: 10.1136/bmjopen-2023-076791. ...

Substance Use Emergency Department Visits Among Youths With Chronic Conditions During COVID-19.  Summersett Williams F, Zaniletti I, Masonbrink AR, et al.  JAMA Netw Open. 2024;7(10):e2435059. doi:10.1001/jamanetworkopen.2024.3505...

The origin of the COVID-19 pandemic has sparked much debate, and various hypotheses have been put forward. "My colleagues and I have examined the issue with an open mind, taking into account all possible hypotheses. The laboratory origin hypothes...

The Collaborative Outcome Study on Health and Functioning during Infection Times (COH-FIT): Results from Cyprus.  Papatriantafyllou E, Efthymiou D, Felekkis K, Solmi M, Correll CU, Thompson T, Estradé A, Tsokani S, Kontouli KM, Seitidis G, K...

The Odyssey of HOMER: Comparative Effectiveness Research on Medication for Opioid Use Disorder During the COVID-19 Pandemic.  Zittleman L, Westfall JM, Sofie B, Lutgen C, Fernald D, Hall TL, Hochheimer CJ, Murphy M, Felzien M, Dickinson LM, ...